Aplicação de líquidos ativados com plasma frio na endodontia / Application of plasma-activated liquids in endodontics

O insucesso do tratamento endodôntico é decorrente principalmente da presença de microrganismos remanescentes no canal radicular decorrente da dificuldade de remoção de biofilmes e das limitações dos irrigantes convencionais. Por este motivo, há necessidade de novas alternativas para a desinfecção intracanal. O objetivo deste estudo foi avaliar a atividade inibitória de líquidos ativados por plasma frio sobre biofilmes de interesse endodôntico, além de caracterizar as condições para obtenção do líquido ativado e analisar a citotoxicidade dos líquidos. Biofilmes mono e dual espécies de 24 horas foram obtidos a partir de suspensões padronizadas de Candida albicans (ATCC 18804) e Enterococcus faecalis (ATCC 29212). Os biofilmes foram expostos aos líquidos ativados, sendo estes água destilada, solução fisiológica e água mineral. Foram incluídos grupos de líquidos não ativados (controles negativos) e grupo controle de crescimento. Após 24 horas, os biofilmes foram expostos ao tratamento por 2 períodos, 1 minuto e 1,5 minutos. O número de células remanescentes foi determinado após semeadura da suspensão microbiana resultante em meios de cultura seletivos. A citotoxicidade dos líquidos ativados frente às células 3T3 foi avaliada. O teste ex vivo foi realizado em canais radiculares de dentes humanos, no qual totalizou 54 dentes humanos unirradiculares que foram preparados, instrumentados e esterilizados para receberem tratamentos com água destilada ativada. Os dados foram analisados pelo software GraphPad Prism, versão 6.01. As comparações foram feitas utilizando testes de análise de variância (ANOVA One-way), seguidas do post-hoc de Tukey, adotando-se o nível de significância de 5%. A exposição dos líquidos ativados por plasma frio levou a reduções significativas (p<0.0001) em todos os grupos quando comparados ao grupo controle de crescimento e com os grupos dos líquidos não ativados, tanto para biofilmes mono e dual espécies. A Água destilada ativada levou à maior redução em relação aos demais líquidos e o tempo de tratamento mais efetivo foi de 1,5 minutos. Os líquidos ativados não foram citotóxicos para células 3T3. No teste ex vivo, a água destilada ativada levou à redução da viabilidade dos biofilmes em 80% a 91%. Conclui-se os líquidos ativadas com plasma frio apresentaram ação inibitória sobre biofilmes mono e dual espécies formados por C. albicans e E. faecalis, tanto em modelo in vitro quanto ex vivo, com ausência de toxicidade para células 3T3.(AU)

The failure of endodontic treatment is mainly due to the presence of remaining microorganisms in the root canal due to the difficulty in removing biofilms and the limitations of conventional irrigants. For this reason, there is a need for new alternatives for intracanal disinfection. The objective of this study was to evaluate the inhibitory effect of by cold plasma activated liquids on biofilms of endodontic interest, in addition to characterizing the conditions for obtaining the activated liquid and analyzing the cytotoxicity of the liquids. 24-hours mono- and dual-species biofilms were obtained from standardized suspensions of Candida albicans (ATCC 18804) and Enterococcus faecalis (ATCC 29212). The biofilms were exposed to the activated liquids, which were distilled water, saline solution and mineral water. Non-activated liquid groups (negative controls) and growth control group were included. After 24 hours, the biofilms were exposed to treatment for 2 periods, 1 minute and 1.5 minutes. The number of remaining cells was determined by plating method using selective culture media. The cytotoxicity of activated liquids on 3T3 cells was evaluated. The ex vivo assays were carried out in root canals of human teeth. A total of 54 single-rooted human teeth were prepared, instrumented and sterilized to receive treatments with activated distilled water. Data were analyzed using GraphPad Prism software, version 6.01. Comparisons were made using analysis of variance tests (One-way ANOVA), followed by Tukey's posthoc test, adopting a significance level of 5%. Significant reduction of cell viabilities (p<0.0001) in all groups were observed after exposure to plasma activated liquids when compared to the growth control group and the non-activated liquid groups, both for mono and dual species biofilms. Activated distilled water led to the greatest reduction compared to other liquids and the most effective treatment time was 1.5 minutes. The activated liquids were not cytotoxic to 3T3 cells. In the ex vivo assay, activated distilled water led to a reduction in biofilm viability from 80% to 91%. It is concluded that plasma activated liquids showed inhibitory action on mono and dual species biofilms formed by C. albicans and E. faecalis, both in in vitro and ex vivo models, with no toxicity for 3T3 cells (AU)

Tumor antigen-loaded dendritic cells combined with cytokine-induced killer (CIK) enhance the killing activity of human esophageal cancer cells by promoting ASK1 activation / 细胞与分子免疫学杂志

Objective To clarify the effect and mechanism of tumor antigen-loaded dendritic cells (Ag-DCs) combined with cytokine-induced killers (CIKs) on the killing of esophageal cancer tumor cells. Methods Peripheral blood DCs and CIKs were induced and cultured, and the DCs were loaded with tumor antigen to obtain Ag-DCs, and Ag-DCs were co-cultured with CIKs. The experiment was divided into CIK group, DC combined with CIK group, Ag-DC combined with CIK group. Flow cytometry was used to detect the phenotype of cells. MTT assay was employed to determine the killing activity against EC9706 cells. Annexin V-FITC/PI double staining was used to detect the apoptosis rate of cells, immunofluorescence staining to detect the expression of phosphorylated apoptotic signal-regulated kinase 1 (p-ASK1) and Western blot analysis to detect the expression of ASK1 pathway related proteins. A nude mouse model of esophageal cancer transplantation tumor was constructed and divided into control group, DC combined with CIK group and Ag-DC combined with CIK group. The corresponding immune cells were injected into the tail vein for treatment and the tumor volume was measured every 2 days. After 21 days, all nude mice were sacrificed with the tumors taken out. HE staining was used to observe the tumor pathological changes and immunohistochemical staining was performed to detect the expression of ki67 and ASK1 in the tumor tissue. Results Comparedwith the CIK group alone and the DC combined with CIK group, the ratio of CD3+ CD8+ and CD3+ CD56+ in the cells significantly increased after Ag-DCs and CIKs co-culture, along with the increased killing rate of EC9706 cells, increased apoptosis rate of EC9706 cells, and the improved activation level of ASK1. Compared with the CIK group and the DC combined with CIK group, the growth of the transplanted tumor in nude mice treated with Ag-DCs combined with CIKs was significantly inhibited, and after 21 days, it was observed that the tumor tissue mass in this group was relatively smaller, with sparsely arranged cells in the tumor tissue and a decline in the positive rate of ki67 in tumor tissue, while the positive rate of ASK1 was significantly increased. Conclusion Co-cultivation of tumor antigen-loaded DCs with CIKs can significantly increase the killing activity of esophageal cancer tumor cells. The mechanism of action may be related to the activation of the ASK1 pathway.

Cytotoxic effect of hydroalcoholic extract of Annona Muricata against a human cell line of gastric adenocarcinoma / Efecto citotóxico del extracto hidroalcoholico de la Annona Muricata frente a la línea celular humana de adenocarcinoma gástrico

Background: Therapeutic advances against cancer have not been as successful as expected and have adverse effects that patients rarely tolerate. A study in Peru identified favorable anticancer effects of Annona muricata (AM), a medicinal plant known as soursop, in C-678 mouse gastric adenocarcinoma. However, to date, no results have been reported in human cells. Objective: The objective of this study was to determine the cytotoxic effect of AM extract against a human gastric adenocarcinoma cell line (AGS). Methodology: Experimental in vitro analytical study using a hydroalcoholic extract of AM (AMOH) leaves collected in the Amazonas. Chemical functional groups were identified by phytochemical screening. To obtain the cytotoxic effect, different dilutions of extract were added to the plates containing the cell lines and the data were extrapolated to GraphPad employing an observation card. Finally, the cytotoxic effect was expressed as the half-maximal inhibitory concentration (IC50) and nonlinear regression analysis was performed to determine the growth inhibition of cancer cells. Results: Phytochemical screening showed the presence of reducing carbohydrates, alkaloids, phenols, tannins, triterpenes, steroids, saponins, flavonoids, proteins, cardiac glycosides, and anthocyanins. A calibration curve with gallic acid was used to determine the total phenol content and, quercetin was used to identify the flavonoid content. The AGS cell line showed cytotoxic activity with AMOH with an IC50 at 24 hours of 45.81 µg/mL and 19.05 µg/mL at 48 hours. Conclusion: Several chemical functional groups of AM were identified. In addition, the AMOH showed a cytotoxic effect against the AGS cell line

Antecedente: Los avances terapéuticos frente al cáncer no han tenido el éxito esperado y presentan efectos adversos pocas veces tolerados por el paciente. Un estudio en Perú identificó el efecto anticancerígeno de la Annona muricata (AM), planta medicinal conocida como guanábana, en adenocarcinoma gástrico de ratón C-678 con resultados favorables, sin embargo, no se ha encontrado evidencia previa en células humanas. Objetivo: El objetivo de este estudio fue determinar el efecto citotóxico del extracto de AM frente a la línea celular de adenocarcinoma gástrico humano (AGS). Materiales y métodos: Estudio experimental in vitro tipo analítico con extracto hidroalcohólico de hojas de AM (AMOH) recolectadas en Amazonas. Mediante screening fitoquímico se identificaron los grupos funcionales químicos. Para obtener el efecto citotóxico, se añadieron diferentes diluciones de extracto a las placas que contienen las líneas celulares y mediante una ficha de observación los datos fueron extrapolados a GraphPad. Finalmente se expresó como la concentración inhibitoria media máxima (IC50) y se hizo un análisis de regresión no lineal con la finalidad de encontrar la cantidad de inhibición de crecimiento de células oncológicas. Resultados: En el screening fitoquímico se pudo identificar la presencia de carbohidratos reductores, alcaloides, fenoles, taninos, tritérpenos y esteroides, saponinas, flavonoides, proteínas, glicósidos cardiotónicos y antocianinas. Para identificar el contenido total de fenoles se utilizó la curva de calibración con ácido gálico el cual nos comprobó la presencia de una buena cantidad de estos metabolitos. Adicionalmente se utilizó quercetina para identificar el contenido de flavonoides, obteniendo resultados favorables ya que se hizo evidente su presencia. La línea celular AGS mostró una actividad citotóxica frente al AMOH con un IC50 a las 24 horas de 45.81ug/mL y 19.05ug/mL a las 48 horas. Conclusión: Se identifica a los grupos funcionales de la AM. Además, AMOH demostró un efecto citotóxico contra la línea celular AGS

Assessment of cytotoxicity, genotoxicity, and mutagenicity of the dexchlorpheniramine reference standard and pharmaceutical formula in human peripheral blood mononuclear cells

Abstract Dexchlorpheniramine is a first-generation classical antihistamine, clinically used to treat allergies. The main objective of our study was to evaluate the effects of the dexchlorpheniramine reference standard (DCPA Ref. St) and a pharmaceutical formula on DNA in human peripheral blood mononuclear cells (PBMCs). We exposed PBMCs to five different concentrations (0.5, 2.5, 5, 10, and 50 ng/mL) of DCPA Ref. St DCPA Ref. St and pharmaceutical formula in order to evaluate their cytotoxic, genotoxic, and mutagenic potential. The results showed that both dexchlorpheniramine formulations did not affect PBMC viability and CD3+, CD4+, or CD8+ lymphocyte subpopulations. The DCPA Ref. St and pharmaceutical formula neither induced genotoxic or mutagenic effects nor numerical or structural chromosomal alterations in PBMCs after 24 hours of exposure.

Effects of hydroxyurea on cytotoxicity, inflammation and oxidative stress markers in neutrophils of patients with sickle cell anemia: dose-effect relationship

ABSTRACT Introduction: Although the efficacy of hydroxyurea (HU) in inhibiting erythrocyte sickling has been well demonstrated, the action of this drug on human neutrophils and the mechanism by which it improves the manifestations of the disease have not been studied thoroughly. We aimed to investigate the cell viability, along with inflammatory and oxidative markers in the neutrophils of sickle cell anemia (SCA) patients and the effects of HU therapy on these cells, by evaluating the dose-responsiveness. Methods: In the present study, 101 patients (45 men and 56 women, aged 18-69 years) with SCA were divided into groups according to the use or not of HU: the SS group (without HU treatment, n = 47) and the SSHU group (under HU treatment, n = 54). The SSHU group was further stratified into subgroups according to the daily dose of the drug that patients already used: SSHU - 0.5 g (n = 19); SSHU - 1 g (n = 26) and SSHU - 1.5-2 g (n = 9). A control group (AA) comprised 50 healthy individuals. Neutrophils isolated from whole blood were analyzed using Trypan Blue, monoiodotyrosine (MTT) and lactate dehydrogenase (LDH) toxicity assays. Myeloperoxidase (MPO), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) activities and concentrations of interleukin 10 (IL-10), tumor necrosis factor alpha (TNF-α) and malonaldehyde (MDA) were also measured. Results: Neutrophils from SCA patients showed membrane fragility and a significant decrease in cell viability when analyzed by Trypan Blue (p < 0.05), MTT (p < 0.001) and LDH (p = 0.011), compared to the AA group. Levels of inflammatory (MPO, TNF-α, and IL-10) and oxidative markers (SOD, GSH-Px, and MDA) were also altered (p < 0.05) in these cells, showing a significant difference in the SSHU-1g and SSHU - 1.5-2 g groups, compared to the SS group. Treatment with HU reverted the levels of all markers to concentrations similar to those in healthy individuals in a positive dose-effect relationship. Conclusion: The HU did not generate a cytotoxic effect on neutrophils in SCA patients, but it modulated their oxidative and inflammatory mechanisms, promoting cytoprotection with a positive dose-effect.

In vitro evaluation of hydroxyapatite, chitosan, and carbon nanotube composite biomaterial to support bone healing / Avaliação in vitro do biomaterial compósito à base de hidroxiapatita, quitosana e nanotubo de carbono como adjuvante no reparo ósseo

Hydroxyapatite, chitosan, and carbon nanotube composite biomaterial were developed to improve bone healing. Previous studies suggested that a combination of biomaterials and mesenchymal stem cells (MSCs) can potentially help promote bone regeneration. In the present study, we first developed hydroxyapatite, chitosan, and carbon nanotube composite biomaterial. Then, the effect of different concentrations of the extract on the viability of Vero cells (ATCC CCL-81) and MSCs obtained from sheep bone marrow using methylthiazol tetrazolium (MTT) and propidium iodide (PI) assays were evaluated. The biomaterial group demonstrated an absence of cytotoxicity, similar to the control group. Samples with 50% and 10% biomaterial extract concentrations showed higher cell viability compared to samples from the control group (MTT assay). These results suggest that the presence of this composite biomaterial can be used with MSCs. This study also concluded that hydroxyapatite, chitosan, and carbon nanotube composite biomaterial were not cytotoxic. Therefore, these could be used for performing in vivo tests.(AU)

O compósito à base de hidroxiapatita, quitosana e nanotubo de carbono foi desenvolvido com o intuito de auxiliar na consolidação óssea. Estudos anteriores sugerem que a combinação de substitutos ósseos e células-tronco mesenquimais (CTM) podem auxiliar a potencializar e promover a regeneração óssea. No presente estudo, o biomaterial foi desenvolvido e a viabilidade e a citotoxicidade de células Vero (ATCC CCL-81) e CTM obtidas de medula óssea provenientes de ovinos utilizando ensaios metil-tiazol-tetrazólio, MTT e iodeto de propídeo (PI) foram avaliadas em diferentes concentrações de extrato desse compósito. O compósito demonstrou ausência de citotoxicidade com comportamento semelhante ao grupo controle. Amostras com 50% e 10% de concentração de extrato do compósito mostraram resultados maiores comparados ao grupo controle (ensaio MTT). Esses resultados também sugerem que a presença do biomaterial pode ser utilizada em associação a CTM. Assim, esse estudo conclui que o compósito apresentado de hidroxiapatita, quitosana e nanotubo de cabono não foi considerado citotóxico e pode ser utilizado em teste in vivo.(AU)

Citotoxicidade, genotoxicidade e expressão gênica em células-tronco mesenquimais expostas a materiais endodônticos / Cytotoxicity, genotoxicity and gene expression in mesenchymal stem cells exposed to endodontic cements

No mercado encontramos uma grande variedade de materiais endodônticos disponibilizados para uso clínico, mas diversos estudos mostram divergências de opiniões com relação ao comportamento biológico dos diferentes materiais. Este trabalho teve como objetivos investigar a viabilidade celular, a expressão de genes envolvidos na plasticidade celular e a diferenciação celular em culturas de células- tronco recuperadas de polpa dentária humana (hDPSCs) quando em contato com quatro materiais endodônticos (Endofill, Pulp Canal Sealer, Sealer 26, MTA) rotineiramente utilizados na clínica odontológica. Objetivou também, por meio de uma revisão sistemática, analisar a biocompatibilidade de cimentos de uso endodôntico sobre células tronco de origem dental. Para isto, o metabolismo celular das hDPSCs, quando em contato com os capilares contendo ou não os cimentos, foi avaliado pelo ensaio de MTT (24 e 48 horas) e a viabilidade celular foi analisada pelo ensaio de exclusão do azul de tripan (48 horas). A plasticidade celular, na presença dos capilares contendo ou não os cimentos, foi avaliada pela expressão gênica dos marcadores CD34, CD45, Nestin, CD105, Nanog e OCT-4 por PCR. Finalmente, a diferenciação celular frente aos cimentos endodônticos foi verificada pela expressão dos genes RUNX2, ALP, OC/BGLAP e DMP1 por RT-PCR. Os dados foram analisados pelo teste ANOVA com correção de Bonferroni (p<0.05). Observou-se que os cimentos Pulp Canal Sealer e o Endofill reduziram significativamente a viabilidade e o metabolismo celular quando comparados ao controle após 48 horas (p<0.001). O MTA e o Sealer 26 não interferiram na viabilidade celular em ambos os períodos de avaliação (p>0.05). As hDPSCs, quando cultivadas na presença do MTA e Sealer 26, expressaram os marcadores Nestin, CD105, NANOG e OCT-4, e não expressaram CD34 e CD45. Por sua vez, o MTA e o Sealer 26 interferiram positivamente ou negativamente na expressão gênica de DMP1, OC/BGLAP e RUNX2 em relação ao grupo controle (p<0.05), mas não houve diferença significativa em relação à expressão gênica de ALP (p>0.05). Portanto, MTA e Sealer 26 demonstram boa compatibilidade biológica quando na presença das hDPSCs. A revisão sistemática demonstrou que a maioria dos materiais, apresentam boa compatibilidade quando em contato com as células tronco, estando aptos a serem utilizados na prática clínica.

On the market, we found a wide variety of endodontics cements available for clinical use, but several studies show divergences of opinion regarding the biological behavior of these different materials. This work aimed to investigate cell viability and metabolism, an expression of genes involved in cell plasticity and cell differentiation in stem cell cultures recovered from human dental pulp (hDPSCs) when in contact with four endodontic cements (Endofill, MTA, Pulp Canal Sealer, Sealer 26) routinely used in endodontic clinic. It also aimed, through a systematic review, to analyze the biocompatibility of endodontic materials on dental stem cells. For this, the viability and metabolism of hDPSCs, when it comes into contact with capillaries that included or not cements, was assessed by MTT assay (24 and 48 hours) and exclusion of trypan blue assay (48 hours). Cellular plasticity, with the presence of capillaries containing or not sealers, was evaluated by the genetic expression of the markers CD34, CD45, Nestin, CD105, Nanog and OCT-4 by PCR. Finally, cell differentiation from endodontics sealers was verified by the expression of the RUNX2, ALP, OC/BGLAP and DMP1 genes by RT-PCR. The data were analyzed using the ANOVA test with Bonferroni correction (p<0.05). We note that Pulp Canal Sealer and Endofill sealers decrease cell viability and cellular metabolism when compared to control after 48 hours (p<0.001). MTA and Sealer 26 did not interfere with cell viability in the two evaluation periods (p>0.05). hDPSCs, when grown in the presence of MTA and Sealer 26, express the Nestin, CD105, NANOG and OCT-4 markers, and do not express CD34 and CD45. In turn, MTA and Sealer 26 interfered in the gene expression of DMP1, OC/BGLAP and RUNX2 in relation to the control group (p<0.05), but did not find a significant difference in relation to the ALP gene expression (p>0.05). Therefore, MTA and Sealer 26 demonstrate good biological compatibility when in the presence of hDPSCs. The systematic review showed that almost all materials have good compatibility when in contact with stem cells, being able to be used in clinical practice.

Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies

ABSTRACT Introduction: Adoptive transfer of T cells expressing a CD19-specific chimeric antigen receptor (CAR) has shown impressive response rates for the treatment of CD19 + B-cell malignancies in numerous clinical trials. The CAR molecule, which recognizes cell-surface tumor-associated antigen independently of human leukocyte antigen (HLA), is composed by one or more signaling molecules to activate genetically modified T cells for killing, proliferation, and cytokine production. Objectives: In order to make this treatment available for a larger number of patients, we developed a simple and efficient platform to generate and expand CAR-T cells. Methods: Our approach is based on a lentiviral vector composed by a second-generation CAR that signals through a 41BB and CD3-ζ endodomain. Conclusions: In this work, we show a high-level production of the lentiviral vector, which was successfully used to generate CAR-T cells. The CAR-T cells produced were highly cytotoxic and specific against CD19+ cells in vitro and in vivo, being able to fully control disease progression in a xenograft B-cell lymphoma mouse model. Our work demonstrates the feasibility of producing CAR-T cells in an academic context and can serve as a paradigm for similar institutions. Nevertheless, the results presented may contribute favoring the translation of the research to the clinical practice.

Effects and Mechanism of PARP Inhibitor Olaparib on the Expression of NKG2D Ligands in HL-60 Cells / 中国实验血液学杂志

OBJECTIVE@#To investigate the regulatory effects of Olaparib on natural killer cell activating receptor (NKG2D) ligands expression on human acute myeloid leukemia (AML) cell line HL-60, and to explore the molecular mechanism of Olaparib on HL-60 cells.@*METHODS@#After HL-60 cells in logarithmic growth phase were treated with Olaparib at different concentrations for different times (24, 48 h), the expression of NKG2D ligand on the surface of HL-60 cells was detected by flow cytometry. Western blot was used to dectect the expression of ERK expression in HL-60 cells. The killing effect of NK cells to HL-60 cells was detected by CFSE/PI method.@*RESULTS@#10 μmol/L Olaparib could upregulate the expression of NKG2D ligand on the surface of HL-60 cell at 24 and 48 hours, while 5 μmol/L Olaparib could induce up-regulation of the expression of ULBP-2 and ULBP-3 at 48 hours. Western blot analysis showed that ERK phosphorylation of HL-60 cells was enhanced after treating with Olaparib. The killing effect of NK cells to HL-60 cells could be enhanced by Olaparib, however, ERK inhibitor could suppress the killing effect of NK cells to HL-60 cells.@*CONCLUSION@#Olaparib can upregulate NKG2D ligands expression on the surface of HL-60 cells and enhance the cytotoxicity of NK cell to HL-60 cells. The mechanism may be related to Olaparib promoting ERK phosphorylation expression.

Os efeitos da Punica granatum L. em diferentes concentrações sobre duas linhagens celulares: estudo in vitro / The effects of Punica granatum L. at different concentrations on two cell lines: in vitro study

Introdução: A Punica granatum L. (PG), utilizada como medicamento fitoterápico, apresenta propriedades terapêuticas, anti-inflamatórias e antioxidante. Embora diversos estudos já tenham sido realizados com este fitoterápico, seus possíveis efeitos citotóxicos nos tecidos humanos ainda não são claros. Objetivo: Avaliar a citotoxicidade da PG por meio de cultura celular com duas linhagens: fibroblastos humanos de mucosa oral (FLM) e células de carcinoma epidermoide oral humano (KB). Material e método: As células foram submetidas ao teste de viabilidade celular por 24 horas nas concentrações da PG 1%, 0,50%, 0,25%, 0,125%, 0,062% e 0,031%, e aos testes de citotoxicidade celular em 4 horas, 1, 3, 5 e 7 dias, em diferentes concentrações, realizados em triplicata. Foi utilizado um controle negativo (Triton 1%) e um controle positivo sem o extrato de PG. Os dados obtidos foram submetidos à ANOVA (p < 0,05). Resultado: Foi possível observar que o extrato da PG possui efeitos inibitórios, apresentando-se maior nas células KB em relação às FLM. Os testes de citotoxicidade e viabilidade mostraram inibição e morte das células KB e FLM nas concentrações 1%, 0,50% e 0,25%. Conclusão: O efeito inibitório da PG foi dose-dependentes, mostrando-se maior nas células KB em relação às FLM.

Introduction: Punica granatum L. (PG), used as a herbal medicine, has therapeutic, anti-inflammatory and antioxidant properties, although several studies have already been carried out with this herbal medicine, its possible cytotoxic effects on human tissues are still unclear. Objective: To evaluate the cytotoxicity of PG through cell culture with two strains: human oral mucosa fibroblasts (LFM) and human oral squamous cell carcinoma (KB) cells. Material and method: The cells were submitted to the cell viability test for 24 hours in the concentrations of PG 1%, 0.50%, 0.25%, 0.125%, 0.062% and 0.031% and the cell cytotoxicity tests in 4 hours, 1, 3, 5 and 7 days in different concentrations, performed in triplicate. A negative control (Triton 1%) and a positive control without the PG extract were used. The data obtained were submitted to ANOVA (p <0.05). Result: it was possible to observe that the PG extract has inhibitory effects, being higher in KB cells in relation to LFM. The cytotoxicity and viability tests showed inhibition and death of KB and FLM cells at concentrations of 1%, 0.50% and 0.25%. Conclusion: The inhibitory effect of PG was dose dependent, showing itself to be greater in KB cells compared to LMB.